login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
IRONWOOD PHARMACEUTICALS INC (IRWD) Stock News
NASDAQ:IRWD -
US46333X1081
-
Common Stock
1.155
USD
+0.05 (+5%)
Last: 9/5/2025, 8:23:03 PM
1.1101
USD
-0.04 (-3.89%)
After Hours:
9/5/2025, 8:23:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IRWD Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Benzinga
- Mentions:
GTLB
CRDO
ZOOZ
JEM
...
Why American Eagle Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
16 days ago - By: Zacks Investment Research
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
a month ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
EXAS
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
a month ago - By: The Motley Fool
Ironwood (IRWD) Q2 EPS Jumps 600%
3 months ago - By: Zacks Investment Research
- Mentions:
ZTS
Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report?
a month ago - By: Zacks Investment Research
- Mentions:
PRPH
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
a month ago - By: Benzinga
- Mentions:
EXAS
TNDM
OM
GH
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
a month ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
4 months ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
ANIP
IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
4 months ago - By: Yahoo Finance
- Mentions:
JNJ
HD
ABBV
TMO
...
Is Johnson & Johnson (JNJ) the Best Dow Stock?
4 months ago - By: Zacks Investment Research
- Mentions:
CRON
Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates
4 months ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
4 months ago - By: Yahoo Finance
- Mentions:
TTWO
MAT
SRAD
VVOS
...
Take-Two price target lowered to $236 from $240 at BMO Capital
4 months ago - By: Zacks Investment Research
- Mentions:
VVOS
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
4 months ago - By: Zacks Investment Research
Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for
4 months ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
4 months ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
5 months ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
5 months ago - By: Yahoo Finance
- Mentions:
BMY
VZ
GILD
VERV
...
Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?
5 months ago - By: Zacks Investment Research
- Mentions:
BIIB
BMY
VERV
Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News
5 months ago - By: Yahoo Finance
- Mentions:
NVS
JNJ
BIDU
CXDO
...
J&J projects $400m tariff hit but raises sales outlook
5 months ago - By: Yahoo Finance
- Mentions:
VZ
GS
JNJ
NVDA
...
J&J sees tariff impact from exports to China more than global imports: CFO
Please enable JavaScript to continue using this application.